Avantor Inc
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone m… Read more
Avantor Inc (AVTR) - Total Liabilities
Latest total liabilities as of December 2025: $6.23 Billion USD
Based on the latest financial reports, Avantor Inc (AVTR) has total liabilities worth $6.23 Billion USD as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Avantor Inc - Total Liabilities Trend (2016–2025)
This chart illustrates how Avantor Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Avantor Inc Competitors by Total Liabilities
The table below lists competitors of Avantor Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hengli Petrochemical Co Ltd
SHG:600346
|
China | CN¥209.43 Billion |
|
Everus Construction Group Inc
NYSE:ECG
|
USA | $1.05 Billion |
|
Ingenic Semiconductor
SHE:300223
|
China | CN¥1.11 Billion |
|
NEPI Rockcastle PLC
AS:NRP
|
Netherlands | €3.85 Billion |
|
Wingstop Inc
NASDAQ:WING
|
USA | $1.42 Billion |
|
CAR Group Ltd
AU:CAR
|
Australia | AU$1.89 Billion |
|
AVIC Jonhon Optronic Technology Co Ltd
SHE:002179
|
China | CN¥16.19 Billion |
|
Torrent Pharmaceuticals Limited
NSE:TORNTPHARM
|
India | ₹70.66 Billion |
Liability Composition Analysis (2016–2025)
This chart breaks down Avantor Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.78 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.12 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.53 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Avantor Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Avantor Inc (2016–2025)
The table below shows the annual total liabilities of Avantor Inc from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $6.23 Billion | +1.17% |
| 2024-12-31 | $6.16 Billion | -20.24% |
| 2023-12-31 | $7.72 Billion | -10.32% |
| 2022-12-31 | $8.61 Billion | -11.25% |
| 2021-12-31 | $9.70 Billion | +34.13% |
| 2020-12-31 | $7.23 Billion | -1.08% |
| 2019-12-31 | $7.31 Billion | -43.60% |
| 2018-12-31 | $12.96 Billion | -0.79% |
| 2017-12-31 | $13.07 Billion | +693.65% |
| 2016-12-31 | $1.65 Billion | -- |